Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells

Cancer Research

Volumn 62, Issue 9, 2002, Pages 2721-2727

  Pidgeon, Graham P ^a   Kandouz, Mustapha ^a   Meram, Anthony ^a   Honn, Kenneth V ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONIC ACID; BAICALEIN; CASPASE 3; CASPASE 7; HYDROXYICOSATETRAENOIC ACID; N BENZYL N HYDROXY 5 PHENYLPENTAMIDE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN P107; PROTEIN P130; RETINOBLASTOMA PROTEIN; SURVIVIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARACHIDONIC ACID METABOLISM; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL LYSATE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

12-HYDROXY-5,8,10,14-EICOSATETRAENOIC ACID; APOPTOSIS; ARACHIDONATE 12-LIPOXYGENASE; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BIOTIN; CELL CYCLE; CELL DIVISION; ENZYME INHIBITORS; FLAVANONES; FLAVONOIDS; G1 PHASE; HUMANS; MALE; PHALLOIDINE; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RETINOBLASTOMA PROTEIN; S PHASE; TUMOR CELLS, CULTURED;

EID: 0036570319     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Cellular proliferation and lipid metabolism: Importance of lipoxygenases in modulating epidermal growth factor dependent mitogenesis
2. 12-Lipoxygenase and 12(S)-HETE: Role in cancer metastasis
3. 12(S)-HETE is a mitogenic factor for micro-vascular endothelial cells: Its potential role in angiogenesis
4. Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis
5. The diversity of the lipoxygenase family. Many sequence data but little information on biological significance
6. Lipoxygenases: Occurrence, functions, catalysis, and acquisition of substrate
7. Molecular cloning, primary structure, and expression of the human platelet/erythroleukemia cell 12-lipoxygenase
8. Cloning and sequence analysis of the cDNA for arachidonate 12-lipoxygenase of porcine leukocytes
9. Increase 12-lipoxygenase expression in breast cancer cells and tissues. Regulation by epidermal growth factor
10. The possible involvement of 15-lipoxygenase/ leukocyte type 12-lipoxygenase in colorectal carcinogenesis
11. Platelet-type 12-lipoxygenase in a human prostate carcinoma stimulates angiogenesis and tumor growth
12. 12-Lipoxygenase expression in human melanoma cell lines
13. Lipoxygenase inhibition induced apoptosis, morphological changes, and carbonic anhydrase expression in human pancreatic cancer cells
14. Changes in lipoxygenase activities in human erythroleukemia (HEL) cells during diosgenin-induced differentiation
15. Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell lines of different metastatic potential
16. Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer
17. 12-Lipoxygenase inhibition induced apoptosis in human gastric cancer cells
18. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines
19. Baicalein, a novel apoptotic agent for hepatoma cell lines: A potential medicine for hepatoma
20. Induction of apoptosis in prostate cancer cell lines by a flavanoid, baicalin
21. The cell cycle and cancer
22. 1-phase progression
23. Choosing between growth arrest and apoptosis through the retinoblastoma tumor suppressor protein, Abl and p73
24. Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes
25. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
26. The inhibitors of apoptosis (IAPs) and their emerging role in cancer
27. 5-Lipoxygenase regulates malignant mesothelial cell survival: Involvement of vascular endothelial growth factor
28. TP 53 gene mutations and CCNDI gene amplification in head and neck squamous cell carcinoma cell lines
29. Cyclin D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer
30. Hepatocellular carcinoma results from chronic cyclin DI overexpression in transgenic mice
31. Rb function in cell-cycle regulation and apoptosis
32. Arachidonic acid stimulates prostate cancer cell growth: Critical role of 5-lipoxygenase
33. Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells
34. The 5-lipoxygenase-activating protein (FLAP) inhibitor. MK 886, induces apoptosis independently of FLAP
35. 5-Lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate non-necrotic cell death
36. Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin
37. A novel antiapoptosis gene, survivin, BCL-2, p53 expression in cervical carcinomas
38. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
39. Cyclin D expression is controlled post- transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway
40. Antisense cyclin DI induces apoptosis and tumor shrinkage in human squamous carcinomas